These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20947693)

  • 21. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender.
    Goodnough LT; Price TH; Parvin CA
    J Lab Clin Med; 1995 Jul; 126(1):57-64. PubMed ID: 7602235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin response is inadequate in cancer patients receiving chemotherapy.
    Lee SJ; Kwon JH; Jung CW
    Int J Hematol; 2001 Dec; 74(4):416-20. PubMed ID: 11794697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoiesis, erythropoietin and blood lead levels.
    Liberatori R; Romeo R; Porcelli B; Barabesi L; Sartorelli P
    G Ital Med Lav Ergon; 2011; 33(1):37-40. PubMed ID: 21417137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postnatal changes in erythropoietin levels in untransfused premature infants.
    Brown MS; Phibbs RH; Garcia JF; Dallman PR
    J Pediatr; 1983 Oct; 103(4):612-7. PubMed ID: 6194281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
    Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
    Gowanlock Z; Sriram S; Martin A; Xenocostas A; Lazo-Langner A
    PLoS One; 2016; 11(6):e0157279. PubMed ID: 27310832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.
    Van Vlerken LG; Van Soest H; Janssen MP; Boland GJ; Drenth JP; Burger DM; Siersema PD; Van Erpecum KJ
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1308-15. PubMed ID: 20729740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin.
    Gamucci T; Thorel MF; Frasca AM; Giannarell D; Calabresi F
    Eur J Cancer; 1993; 29A Suppl 2():S13-4. PubMed ID: 8398359
    [No Abstract]   [Full Text] [Related]  

  • 30. Endothelial function does not relate to haemoglobin or serum erythropoietin concentrations and these do not explain the gender difference in endothelial function in healthy middle-aged men and women.
    Tilling L; Hunt J; Jiang B; Sanders TA; Clapp B; Chowienczyk P
    Eur J Clin Invest; 2013 Mar; 43(3):225-30. PubMed ID: 23330826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis.
    Honda H; Ono K; Akizawa T; Nitta K; Hishida A
    Clin Exp Nephrol; 2018 Jun; 22(3):638-646. PubMed ID: 29103135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in serum erythropoietin levels during chemotherapy for lung cancer.
    Saijo Y; Nakai Y; Saito J; Sugawara S; Suzuki S; Numata Y; Motomiya M
    Chemotherapy; 1992; 38(5):281-5. PubMed ID: 1286570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin levels in cobalamin deficiency: comparison of anemic and non-anemic, subtly deficient patients.
    Carmel R; MacPhee RD
    Eur J Haematol; 1992 Mar; 48(3):159-62. PubMed ID: 1559573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis.
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Mioni G
    Transplant Proc; 2001; 33(1-2):2038-40. PubMed ID: 11267615
    [No Abstract]   [Full Text] [Related]  

  • 35. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects.
    Hughes GS; Francome SF; Antal EJ; Adams WJ; Locker PK; Yancey EP; Jacobs EE
    J Lab Clin Med; 1995 Nov; 126(5):444-51. PubMed ID: 7595029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
    Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
    Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum erythropoietin and hemoglobin affinity for oxygen in patients phlebotomized for polycythemia vera.
    Cohen RA; Clemons G; Ebbe S
    Adv Exp Med Biol; 1989; 271():9-15. PubMed ID: 2486292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum erythropoietin levels in the elderly.
    Kario K; Matsuo T; Nakao K
    Gerontology; 1991; 37(6):345-8. PubMed ID: 1765284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin: from bench to bedside.
    Spivak JL
    Trans Am Clin Climatol Assoc; 1991; 102():232-42; discussion 242-4. PubMed ID: 2130563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of erythropoietin and soluble transferrin receptor in the course of pregnancy in non beta thalassemic and beta thalassemic women.
    Bianco I; Mastropietro F; D'Asero C; Graziani B; Piergrossi P; Mezzabotta M; Modiano G
    Haematologica; 2000 Sep; 85(9):902-7. PubMed ID: 10980626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.